Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial 50S ribosomal subunit 23S rRNA peptidyl transferase center (PTC) is the catalytic core of the ribosome, functioning as a ribozyme to facilitate peptide bond formation during protein translation. Located within a highly conserved pocket of the 23S ribosomal RNA, the PTC coordinates the precise orientation of the aminoacyl-tRNA in the A-site and the peptidyl-tRNA in the P-site to catalyze the nucleophilic attack required for peptide bond synthesis. Because of its essential role in bacterial viability, the PTC is a primary therapeutic target for several classes of clinically important antibiotics, including oxazolidinones (e.g., linezolid), phenicols (e.g., chloramphenicol), lincosamides (e.g., clindamycin), and pleuromutilins (e.g., lefamulin). These drugs bind to the 23S rRNA within the PTC, physically obstructing substrate binding or inhibiting the transpeptidation reaction. However, the structural similarity between bacterial ribosomes and human mitochondrial ribosomes can lead to off-target toxicity, such as myelosuppression and lactic acidosis, during prolonged therapy. Additionally, the clinical utility of PTC-targeting drugs is increasingly threatened by resistance mechanisms, including point mutations in the 23S rRNA or the acquisition of methyltransferases like Cfr, which chemically modify the ribosomal binding site.
Inhibition of bacterial protein synthesis by binding to the 23S rRNA at the peptidyl transferase center, thereby blocking peptide bond formation or preventing the binding of aminoacyl-tRNA to the A-site.
12 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial 50S ribosomal subunit 23S rRNA peptidyl transferase center (PTC).